FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311148086> ?p ?o ?g. }

• W4311148086 endingPage "e205" @default.
• W4311148086 startingPage "e199" @default.
• W4311148086 abstract "Uterine serous carcinoma (USC) is an aggressive subtype of endometrial cancer with high rates of relapse and death. As adjuvant therapy might be beneficial in early-stage disease, the impact of standard complete surgical staging is questioned. Therefore, we wanted to explore the optimal treatment strategy for women diagnosed with USC.A retrospective multicentre study of women diagnosed with primary USC in the UK and the Netherlands. Treatment strategy in relation to overall survival and progression-free survival was recorded and evaluated with Kaplan-Meier and Cox regression analysis. Furthermore, primary surgical staging and/or adjuvant treatment in relation to patterns of recurrence were evaluated.In total, 272 women with a median age of 70 years were included. Most patients presented with International Federation of Gynecology and Obstetrics (FIGO) stage I disease (44%). Overall, 48% of patients developed recurrent disease, most (58%) with a distant component. Women treated with chemotherapy showed significantly better overall survival (hazard ratio 0.50, 95% confidence interval 0.31-0.81; P = 0.005) and progression-free survival (hazard ratio 0.48, 95% confidence interval 0.28-0.80; P = 0.04) in multivariable analysis. Furthermore, even in surgically staged women with FIGO stage IA disease, a high recurrence rate of 42% was seen.Women with USC who received adjuvant chemotherapy showed better survival rates compared with those who received other or no adjuvant treatment. The benefit of adjuvant chemotherapy was observed across all tumour stages, including surgically staged FIGO stage IA. These data question the role of surgical staging in the absence of macroscopic disease in USC." @default.
• W4311148086 created "2022-12-23" @default.
• W4311148086 creator A5017618107 @default.
• W4311148086 creator A5021420651 @default.
• W4311148086 creator A5022653090 @default.
• W4311148086 creator A5024176103 @default.
• W4311148086 creator A5033626519 @default.
• W4311148086 creator A5042992302 @default.
• W4311148086 creator A5045265012 @default.
• W4311148086 creator A5056829692 @default.
• W4311148086 creator A5064807039 @default.
• W4311148086 creator A5065148818 @default.
• W4311148086 creator A5066050350 @default.
• W4311148086 creator A5072024094 @default.
• W4311148086 creator A5083376344 @default.
• W4311148086 date "2023-02-01" @default.
• W4311148086 modified "2023-10-18" @default.
• W4311148086 title "Defining the Optimal Treatment Strategy in Patients With Uterine Serous Carcinoma" @default.
• W4311148086 cites W2016294917 @default.
• W4311148086 cites W2023587700 @default.
• W4311148086 cites W2031222466 @default.
• W4311148086 cites W2031910480 @default.
• W4311148086 cites W2091983588 @default.
• W4311148086 cites W2128772530 @default.
• W4311148086 cites W2166074462 @default.
• W4311148086 cites W2468311487 @default.
• W4311148086 cites W2532858212 @default.
• W4311148086 cites W2605659740 @default.
• W4311148086 cites W2889646458 @default.
• W4311148086 cites W2949349304 @default.
• W4311148086 cites W2963015093 @default.
• W4311148086 cites W3047152751 @default.
• W4311148086 cites W3094417207 @default.
• W4311148086 cites W3097490979 @default.
• W4311148086 cites W3114074286 @default.
• W4311148086 cites W3118289500 @default.
• W4311148086 cites W4207047483 @default.
• W4311148086 doi "https://doi.org/10.1016/j.clon.2022.11.001" @default.
• W4311148086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36509615" @default.
• W4311148086 hasPublicationYear "2023" @default.
• W4311148086 type Work @default.
• W4311148086 citedByCount "1" @default.
• W4311148086 crossrefType "journal-article" @default.
• W4311148086 hasAuthorship W4311148086A5017618107 @default.
• W4311148086 hasAuthorship W4311148086A5021420651 @default.
• W4311148086 hasAuthorship W4311148086A5022653090 @default.
• W4311148086 hasAuthorship W4311148086A5024176103 @default.
• W4311148086 hasAuthorship W4311148086A5033626519 @default.
• W4311148086 hasAuthorship W4311148086A5042992302 @default.
• W4311148086 hasAuthorship W4311148086A5045265012 @default.
• W4311148086 hasAuthorship W4311148086A5056829692 @default.
• W4311148086 hasAuthorship W4311148086A5064807039 @default.
• W4311148086 hasAuthorship W4311148086A5065148818 @default.
• W4311148086 hasAuthorship W4311148086A5066050350 @default.
• W4311148086 hasAuthorship W4311148086A5072024094 @default.
• W4311148086 hasAuthorship W4311148086A5083376344 @default.
• W4311148086 hasConcept C121608353 @default.
• W4311148086 hasConcept C126322002 @default.
• W4311148086 hasConcept C141071460 @default.
• W4311148086 hasConcept C143998085 @default.
• W4311148086 hasConcept C146357865 @default.
• W4311148086 hasConcept C150173356 @default.
• W4311148086 hasConcept C151730666 @default.
• W4311148086 hasConcept C167135981 @default.
• W4311148086 hasConcept C207103383 @default.
• W4311148086 hasConcept C2776694085 @default.
• W4311148086 hasConcept C2777088508 @default.
• W4311148086 hasConcept C2777632260 @default.
• W4311148086 hasConcept C2777982462 @default.
• W4311148086 hasConcept C2778515176 @default.
• W4311148086 hasConcept C2780427987 @default.
• W4311148086 hasConcept C29456083 @default.
• W4311148086 hasConcept C44249647 @default.
• W4311148086 hasConcept C50382708 @default.
• W4311148086 hasConcept C71924100 @default.
• W4311148086 hasConcept C86803240 @default.
• W4311148086 hasConceptScore W4311148086C121608353 @default.
• W4311148086 hasConceptScore W4311148086C126322002 @default.
• W4311148086 hasConceptScore W4311148086C141071460 @default.
• W4311148086 hasConceptScore W4311148086C143998085 @default.
• W4311148086 hasConceptScore W4311148086C146357865 @default.
• W4311148086 hasConceptScore W4311148086C150173356 @default.
• W4311148086 hasConceptScore W4311148086C151730666 @default.
• W4311148086 hasConceptScore W4311148086C167135981 @default.
• W4311148086 hasConceptScore W4311148086C207103383 @default.
• W4311148086 hasConceptScore W4311148086C2776694085 @default.
• W4311148086 hasConceptScore W4311148086C2777088508 @default.
• W4311148086 hasConceptScore W4311148086C2777632260 @default.
• W4311148086 hasConceptScore W4311148086C2777982462 @default.
• W4311148086 hasConceptScore W4311148086C2778515176 @default.
• W4311148086 hasConceptScore W4311148086C2780427987 @default.
• W4311148086 hasConceptScore W4311148086C29456083 @default.
• W4311148086 hasConceptScore W4311148086C44249647 @default.
• W4311148086 hasConceptScore W4311148086C50382708 @default.
• W4311148086 hasConceptScore W4311148086C71924100 @default.
• W4311148086 hasConceptScore W4311148086C86803240 @default.
• W4311148086 hasIssue "2" @default.
• W4311148086 hasLocation W43111480861 @default.

• next